(+)-catechin multiple interactions ISO RGD:1606380 6480464 Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA] CTD PMID:21882252 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions ISO RGD:1305975 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BOLA3 mRNA CTD PMID:25729387 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BOLA3 mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO RGD:1606380 6480464 Lactic Acid results in decreased expression of BOLA3 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1606380 6480464 beta-methylcholine affects the expression of BOLA3 mRNA CTD PMID:21179406 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:1606380 6480464 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA, Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA] CTD PMID:21882252 aflatoxin B1 increases expression ISO RGD:1606380 6480464 Aflatoxin B1 results in increased expression of BOLA3 mRNA CTD PMID:27153756 arsenite(3-) increases methylation ISO RGD:1606380 6480464 arsenite results in increased methylation of BOLA3 promoter CTD PMID:23974009 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of BOLA3 mRNA] CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:1606380 6480464 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA, Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA] CTD PMID:21882252 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of BOLA3 mRNA CTD PMID:22228805 bisphenol A decreases methylation ISO RGD:1606380 6480464 bisphenol A results in decreased methylation of BOLA3 gene CTD PMID:22576693 bisphenol A increases expression ISO RGD:1305975 6480464 bisphenol A results in increased expression of BOLA3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1606380 6480464 bisphenol A results in increased expression of BOLA3 mRNA CTD PMID:22576693 catechin multiple interactions ISO RGD:1606380 6480464 Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA] CTD PMID:21882252 chloropicrin increases expression ISO RGD:1606380 6480464 chloropicrin results in increased expression of BOLA3 mRNA CTD PMID:26352163 cobalt dichloride decreases expression ISO RGD:1606380 6480464 cobaltous chloride results in decreased expression of BOLA3 mRNA CTD PMID:22941251 copper(II) sulfate decreases expression ISO RGD:1606380 6480464 Copper Sulfate results in decreased expression of BOLA3 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1606380 6480464 Cyclosporine results in decreased expression of BOLA3 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1606380 6480464 Cyclosporine results in increased expression of BOLA3 mRNA CTD PMID:25562108 dexamethasone increases expression ISO RGD:1606380 6480464 Dexamethasone results in increased expression of BOLA3 mRNA CTD PMID:25047013 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BOLA3 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of BOLA3 mRNA CTD PMID:21266533 doxorubicin decreases expression ISO RGD:1606380 6480464 Doxorubicin results in decreased expression of BOLA3 mRNA CTD PMID:29803840 ethanol multiple interactions ISO RGD:1606380 6480464 [[Gasoline co-treated with Ethanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BOLA3 mRNA CTD PMID:29432896 finasteride increases expression ISO RGD:1305975 6480464 Finasteride results in increased expression of BOLA3 mRNA CTD PMID:24136188 flutamide increases expression ISO RGD:1305975 6480464 Flutamide results in increased expression of BOLA3 mRNA CTD PMID:24136188 genistein decreases methylation ISO RGD:1305975 6480464 Genistein results in decreased methylation of BOLA3 gene CTD PMID:28505145 glafenine increases expression ISO RGD:1305975 6480464 Glafenine results in increased expression of BOLA3 mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO RGD:1606380 6480464 Hydrogen Peroxide affects the expression of BOLA3 mRNA CTD PMID:21179406 leflunomide increases expression ISO RGD:1305975 6480464 leflunomide results in increased expression of BOLA3 mRNA CTD PMID:24136188 nefazodone increases expression ISO RGD:1305975 6480464 nefazodone results in increased expression of BOLA3 mRNA CTD PMID:24136188 nimesulide increases expression ISO RGD:1305975 6480464 nimesulide results in increased expression of BOLA3 mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO RGD:1305975 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BOLA3 mRNA CTD PMID:25729387 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of BOLA3 mRNA CTD PMID:18301758 , PMID:23811191 poly(vinylpyrrolidone) multiple interactions ISO RGD:1305975 6480464 [Silver analog co-treated with Povidone] results in decreased expression of BOLA3 mRNA CTD PMID:25194297 rac-lactic acid decreases expression ISO RGD:1606380 6480464 Lactic Acid results in decreased expression of BOLA3 mRNA CTD PMID:30851411 silver atom multiple interactions ISO RGD:1305975 6480464 [Silver analog co-treated with Povidone] results in decreased expression of BOLA3 mRNA CTD PMID:25194297 silver(0) multiple interactions ISO RGD:1305975 6480464 [Silver analog co-treated with Povidone] results in decreased expression of BOLA3 mRNA CTD PMID:25194297 silver(1+) multiple interactions ISO RGD:1305975 6480464 [Silver analog co-treated with Povidone] results in decreased expression of BOLA3 mRNA CTD PMID:25194297 thapsigargin decreases expression ISO RGD:1606380 6480464 Thapsigargin results in decreased expression of BOLA3 mRNA CTD PMID:22378314 toluene decreases expression ISO RGD:1305975 6480464 Toluene results in decreased expression of BOLA3 mRNA CTD PMID:22967744 topotecan multiple interactions ISO RGD:1305975 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BOLA3 mRNA CTD PMID:25729387 tungsten increases expression EXP 6480464 Tungsten results in increased expression of BOLA3 mRNA CTD PMID:30912803 tungsten(4+) increases expression EXP 6480464 Tungsten results in increased expression of BOLA3 mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1606380 6480464 Tunicamycin results in decreased expression of BOLA3 mRNA CTD PMID:22378314 valproic acid increases expression ISO RGD:1606380 6480464 Valproic Acid results in increased expression of BOLA3 mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:1606380 6480464 Valproic Acid affects the expression of BOLA3 mRNA CTD PMID:25979313
Gene-Chemical Interaction Annotations
